Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer.
about
Novel 1, 3-N, O-Spiroheterocyclic compounds inhibit heparanase activity and enhance nedaplatin-induced cytotoxicity in cervical cancer cells.Expression of Adiponectin Receptor-1 and Prognosis of Epithelial Ovarian Cancer Patients.Prognostic factors for patients with brain metastasis from gynecological cancer: a significance of treatment-free interval of more than 6 months.Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits.Cervical cancer stem-like cells: systematic review and identification of reference genes for gene expression.The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
P2860
Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Platinum sensitivity and non-c ...... in recurrent cervical cancer.
@ast
Platinum sensitivity and non-c ...... in recurrent cervical cancer.
@en
type
label
Platinum sensitivity and non-c ...... in recurrent cervical cancer.
@ast
Platinum sensitivity and non-c ...... in recurrent cervical cancer.
@en
prefLabel
Platinum sensitivity and non-c ...... in recurrent cervical cancer.
@ast
Platinum sensitivity and non-c ...... in recurrent cervical cancer.
@en
P2093
P2860
P1476
Platinum sensitivity and non-c ...... in recurrent cervical cancer.
@en
P2093
Aki Tanaka
Masakazu Abe
Munetaka Takekuma
Nobutaka Takahashi
Shiho Kuji
Yasuyuki Hirashima
P2860
P304
P356
10.3802/JGO.2015.26.3.185
P577
2015-07-01T00:00:00Z